Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage

Current — Aurobindo Pharma USA

The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from Aurobindo Pharma USA with status Current. The shortage was first posted on Oct 12, 2022. Reported reason: Shortage of an active ingredient

Shortage details

Status
Current
Company
Aurobindo Pharma USA
Package NDC
13107-072-01
Dosage Form
Tablet
Presentation
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01)
Initial Posting
Oct 12, 2022

Reason

Shortage of an active ingredient

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.